MedPath

海口天行健药物研究有限公司

Ownership
-
Established
2005-06-03
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

NMPA:18

Drug Approvals

Carbazochrome Sodium Sulfonate Injection

Product Name
卡络磺钠注射液
Approval Number
国药准字H20254080
Approval Date
May 13, 2025
NMPA

Ketotifen Fumarate Oral Solution

Product Name
富马酸酮替芬口服溶液
Approval Number
国药准字H20254155
Approval Date
May 13, 2025
NMPA

Carbazochrome Sodium Sulfonate Injection

Product Name
卡络磺钠注射液
Approval Number
国药准字H20254081
Approval Date
May 13, 2025
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H20258077
Approval Date
May 9, 2025
NMPA

Amikacin Sulfate Injection

Product Name
硫酸阿米卡星注射液
Approval Number
国药准字H20247230
Approval Date
Sep 30, 2024
NMPA

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20244762
Approval Date
Aug 27, 2024
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20243666
Approval Date
May 8, 2024
NMPA

Sodium Phosphates Oral Solution

Product Name
磷酸钠盐口服溶液
Approval Number
国药准字H20193229
Approval Date
Apr 2, 2024
NMPA

Digoxin Injection

Product Name
地高辛注射液
Approval Number
国药准字H20234528
Approval Date
Jan 10, 2024
NMPA

丹参胶囊

Approval Number
国药准字Z20090210
Approval Date
Aug 30, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.